Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 501–600 of 3,349
Mallah, K., Couch, C., Borucki, D. M., Toutonji, A., Alshareef, M., & Tomlinson, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02021 · Cited by 100
“Similar complement-mediated processes are indicated in other CNS diseases, such as Alzheimer’s disease (25) and Multiple Sclerosis (MS) (26).”
BackgroundMoving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer’s disease
Young‐Pearse, T. L., Lee, H., Hsieh, Y., Chou, V., & Selkoe, D. J. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.03.005 · Cited by 107
Self-citationAlzheimer's disease pathophysiology in the Retina
Gaire, B. P., Koronyo, Y., Fuchs, D.-T. S., Shi, H., Rentsendorj, A., Danziger, R., Vit, J., Mirzaei, N., Doustar, J., Sheyn, J., et al. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101273 · Cited by 111
Hales, C. M., Dammer, E. B., Deng, Q., Duong, D. M., Gearing, M., Troncoso, J. C., Thambisetty, M., Lah, J. J., Shulman, J. M., Levey, A. I., et al. (2016) · PROTEOMICS · doi:10.1002/pmic.201600057 · Cited by 99
“Complement C3 in the brain is primarily expressed by microglia [60], and is essential in the process of microglial-mediated early synaptic loss in AD models [61].”
BackgroundCD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling
Meng, F. J., Guo, Z., Hu, Y., Mai, W., Zhang, Z., Zhang, B., Ge, Q., Lou, H., Guo, F., Chen, J., et al. (2019) · Brain · doi:10.1093/brain/awy351 · Cited by 107
Microglia responses to interleukin‐6 and type I interferons in neuroinflammatory disease
West, P. K., Viengkhou, B., Campbell, I. L., & Hofer, M. J. (2019) · Glia · doi:10.1002/glia.23634 · Cited by 98
Ultra-High-Dose-Rate FLASH Irradiation Limits Reactive Gliosis in the Brain
Montay‐Gruel, P., Markarian, M., Allen, B. D., Baddour, J. D., Giedzinski, E., Jorge, P. G., Petit, B., Bailat, C. J., Vozenin, M., Limoli, C. L., et al. (2020) · Radiation Research · doi:10.1667/rade-20-00067.1 · Cited by 118
Microglial modulation of neuronal activity in the healthy brain
York, E. M., Bernier, L., & MacVicar, B. A. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22571 · Cited by 98
Houck, A. L., Seddighi, S., & Driver, J. A. (2019) · Current Aging Science · doi:10.2174/1874609811666180223154436 · Cited by 95
“Indeed, disruptions in this process have been invariably linked to the earliest stages of a number of neurodegenerative disorders, including AD [126], HD [127], and ALS [128].”
BackgroundHorchar, M. J., & Wohleb, E. S. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.030 · Cited by 98
The role of phosphatidylserine on the membrane in immunity and blood coagulation
Wang, J., Yu, C., Zhuang, J., Qi, W., Jiang, J., Liu, X., Zhao, W., Cao, Y., Wu, H., Qi, J., et al. (2022) · Biomarker Research · doi:10.1186/s40364-021-00346-0 · Cited by 114
“Furthermore, when exposed to soluble Aβ oligomers, microglia in adult brains engulf synaptic material through the CR3dependent process [108].”
BackgroundAlawieyah Syed Mortadza, S., Sim, J. A., Neubrand, V. E., & Jiang, L. (2018) · Glia · doi:10.1002/glia.23265 · Cited by 99
“2018;66:562–575. factor in Alzheimer’s disease (AD), the most common cause of dementia (Hong et al., 2016; Mucke & Selkoe, 2012; Selkoe & Hardy, 2016).”
BackgroundKeaney, J., Gasser, J., Gillet, G., Scholz, D., & Kadiu, I. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09839-0 · Cited by 98
“…roles of microglia in limiting Aβ build-up may act in presymptomatic AD (Wang et al. 2015; Zhao et al. 2018), once inmotion the disease course may be accelerated by microglial-mediated spreading of tau pathology and synapse loss (Asai et al. 2015; Hong et al. 2016; Hansen et al. 2018).”
BackgroundInfluentialTREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment
Jay, T. R., von Saucken, V. E., Muñoz, B., Codocedo, J. F., Atwood, B. K., Lamb, B. T., & Landreth, G. E. (2019) · Glia · doi:10.1002/glia.23664 · Cited by 97
“However, glial developmental functions have been shown to be aberrantly reinitiated in adulthood (Hong et al., 2016) in response to injury, infection or metabolic challenge.”
BackgroundThe complement cascade in Alzheimer’s disease: a systematic review and meta-analysis
Krance, S. H., Wu, C., Zou, Y. Z., Mao, H., Toufighi, S., He, X., Pakosh, M. T., & Swardfager, W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0536-8 · Cited by 108
Bohlson, S. S., & Tenner, A. J. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-035639 · Cited by 115
Role of RhoA/ROCK signaling in Alzheimer’s disease
Cai, R., Wang, Y., Huang, Z., Zou, Q., Pu, Y., Yu, C., & Cai, Z. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113481 · Cited by 96
Engineering pharmaceutical nanocarriers for photodynamic therapy on wound healing: Review
Shanmugapriya, K., & Kang, H. W. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110110 · Cited by 96
Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
Gómez-Isla, T., & Frosch, M. P. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00642-9 · Cited by 96
Long, H., Zhou, Z.-W., Cheng, Y., Luo, H., Li, F., Xu, S., & Gao, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.888989 · Cited by 106
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
“In AD, CR3-mediated elimination of synapses was proposed to lead to the aberrant synapse loss seen early in the disease progression [142, 143].”
BackgroundGlial Control of Synapse Number in Healthy and Diseased Brain
Lee, E., & Chung, W.-S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00042 · Cited by 91
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L., Leverenz, J. B., Cummings, J., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 94
“Microglia mediate synapse loss in AD via a complement‐dependent pathway,(85) and C3 depletion reduced the number of phagocytic microglia, decreased synapse loss, and rescued cognitive deficits in a mouse model of AD.(86) Interestingly, aberrant and sustained microglial activation was re-”
BackgroundPathogenesis of Alzheimer's disease: Involvement of the choroid plexus
Čarná, M., Onyango, I. G., Katina, S., Holub, D., Novotný, J., Nezvedová, M., Jha, D., Nedelská, Z., Lacovich, V., Vyvere, T. V., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12970 · Cited by 112
Neonatal microglia: The cornerstone of brain fate
Pierre, W. C., Smith, P. L. P., Londoño, I., Chemtob, S., Mallard, C. E., & Lodygensky, G. A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.018 · Cited by 110
“Despite that synaptic pruning in the neonate is associated with normal neurodevelopment, in the adult, microglia dependent synaptic pruning through the complement cascade is linked to neurologic diseases such as schizophrenia and Alzheimer disease (Hong et al., 2016; Sekar et al., 2016).”
BackgroundTerminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
Carpanini, S. M., Torvell, M., Bevan, R. J., Byrne, R. A. J., Daskoulidou, N., Saito, T., Saido, T. C., Taylor, P. R., Hughes, T. R., Zelek, W. M., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01404-w · Cited by 95
Shrivastava, A. N., Aperia, A. C., Melki, R., & Triller, A. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.026 · Cited by 98
Is Alzheimer’s disease an inflammasomopathy?
Pereira, C. F., Santos, A. E., Moreira, P. I., Pereira, A. C., Sousa, F. J., Cardoso, S. M., & Cruz, M. T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100966 · Cited by 94
SIRT3 deficiency-induced mitochondrial dysfunction and inflammasome formation in the brain
Tyagi, A., Nguyen, C. U., Chong, T., Michel, C. R., Fritz, K. S., Reisdorph, N. A., Knaub, L. A., Reusch, J. E. B., & Pugazhenthi, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-35890-7 · Cited by 102
Microglia‐dependent remodeling of neuronal circuits
Guedes, J. R., Ferreira, P. A., Costa, J. M., Cardoso, A. L., & Peça, J. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15689 · Cited by 93
“…C3 have been shown to tag synapses for elimination in physiological (Györffy et al., 2018) and pathological conditions, such as Alzheimer's Disease (Hong et al., 2016) or viral infections (Vasek et al., 2016), the opposite has been observed for CD47- labeled synapses, which seem to be protected…”
BackgroundGollihue, J. L., & Norris, C. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101039 · Cited by 93
New insights into mononuclear phagocyte biology from the visual system
Reyes, N. J., O'Koren, E. G., & Saban, D. R. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.13 · Cited by 93
3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice
Gail Canter, R., Huang, W.-C., Choi, H., Wang, J., Ashley Watson, L., Yao, C. G., Abdurrob, F., Bousleiman, S. M., Young, J. Z., Bennett, D. A., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0599-8 · Cited by 89
Carvalho, K., Faivre, E., Pietrowski, M. J., Marques, X., Gomez-Murcia, V., Deleau, A., Huin, V., Hansen, J. N., Kozlov, S., Danis, C., et al. (2019) · Brain · doi:10.1093/brain/awz288 · Cited by 92
“The causal link between C1q upsurge and cognitive dysfunction promoted by ageing or cerebral amyloidosis has been established by the observation that C1q deletion or blockade restored plasticity and memory (Stephan et al., 2013; Hong et al., 2016).”
BackgroundInfluentialThe emerging tale of microglia in psychiatric disorders
Rahimian, R., Wakid, M., O’Leary, L. A., & Mechawar, N. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.023 · Cited by 102
Single-cell transcriptomic analysis of human colonic macrophages reveals niche-specific subsets
Domańska, D., Majid, U., Karlsen, V. T., Merok, M. A., Beitnes, A.-C. R., Yaqub, S., Bækkevold, E. S., & Jahnsen, F. L. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211846 · Cited by 106
“, 2017), synaptic pruning in the brain (Hong et al., 2016), alveolar surfactant clearance in the lung (Guilliams et al.”
BackgroundCrosstalk between endoplasmic reticulum stress and brain inflammation in Alzheimer's disease
Santos, L. E., & Ferreira, S. T. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.016 · Cited by 98
Krukowski, K., Feng, X., Paladini, M. S., Chou, A., Sacramento, K., Grue, K., Riparip, L.-K., Jones, T., Campbell-Beachler, M., Nelson, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26039-7 · Cited by 92
Steele, N. Z. R., Carr, J. S., Bonham, L. W., Geier, E. G., Damotte, V., Miller, Z. A., Desikan, R. S., Boehme, K. L., Mukherjee, S., Crane, P. K., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002272 · Cited by 91
Patten, K. T., Valenzuela, A. E., Wallis, C., Berg, E. L., Silverman, J. L., Bein, K. J., Wexler, A. S., & Lein, P. J. (2021) · Environmental Health Perspectives · doi:10.1289/ehp8905 · Cited by 95
“Activated microglia can also phagocytose synapses (Fonseca et al. 2017; Hong et al. 2016; Stephan et al. 2013), and aberrant micro-glial phagocytosis of synapses has been reported in mouse models of AD (Hong et al. 2016).”
Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation
Gharagozloo, M., Smith, M. D., Jin, J., Garton, T. P., Taylor, M., Chao, A. K., Meyers, K. R., Kornberg, M. D., Zack, D. J., Ohayon, J. M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02366-4 · Cited by 98
Xin, Y., Tian, M., Deng, S., Li, J., Yang, M., Gao, J., Pei, X., Wang, Y., Tan, J., Zhao, F., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03148-z · Cited by 91
“During neuroinflammation, the complement system can be activated to promote the phagocytosis of microglia, leading to inappropriate pruning of synapses [122].”
BackgroundTzioras, M., Daniels, M. J. D., Davies, C., Baxter, P., King, D., McKay, S., Varga, B., Popovic, K., Hernandez, M., Stevenson, A. J., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101175 · Cited by 105
“For instance, in animal models of AD, microglia and astrocytes engulf more synapses both in responsetoA b pathology 16–19 andtau.”
A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion
Flury, A. G., Aljayousi, L., Park, H.-J., Khakpour, M., Mechler, J., Aziz, S., McGrath, J. D., Deme, P., Sandberg, C., Ibáñez, F. G., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.11.018 · Cited by 111
Less can be more: Fine tuning the maternal brain
Pawluski, J. L., Hoekzema, E., Leuner, B., & Lonstein, J. S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.045 · Cited by 91
Litvinchuk, A., Huynh, T. V., Shi, Y., Jackson, R. J., Finn, M. B., Manis, M., Francis, C. M., Tran, A. C., Sullivan, P. M., Ulrich, J. D., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26043 · Cited by 91
“Microglia have been shown to play a role in synapse elimination in mouse models with AD pathology.(33,38) Given that we detected a decrease in cytokines produced by microglia, in addition to a correlation between Iba1 staining and regional synaptic loss in the anti-ApoE ASO-treated mice, we quantified the level of eng…”
BackgroundMethodPatir, A., Shih, B., McColl, B. W., & Freeman, T. C. (2019) · Glia · doi:10.1002/glia.23572 · Cited by 90
“These include TLR signal- ing (TLR1, TLR2), complement pathway (C3AR1, C1QA, and C2), TYROBP signaling (TREM2, TYROBP), and cytoskeletal organization (AIF1, CAPG, and WAS) (Hong et al., 2016; Marinelli et al., 2015; Yeh, Hansen, & Sheng, 2017).”
Glia in neurodegeneration: Drivers of disease or along for the ride?
Gleichman, A. J., & Carmichael, S. T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104957 · Cited by 90
Ertürk, A., Mentz, S., Stout, E. E., Hedehus, M., Dominguez, S. L., Neumaier, L., Krammer, F., Llovera, G., Srinivasan, K., Hansen, D. V., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1898-15.2016 · Cited by 89
“…in a sex-specific way The receptor for the chemokine fractalkine (CX3CR1), which is expressed in peripheral immune cells including macrophages and lymphocytes (Imai et al., 1997; Mionnet et al., 2010), is important for migration and infiltration of these cells (Sheridan and Murphy, 2013).”
BackgroundGlucose metabolism, neural cell senescence and Alzheimer's disease
Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084351 · Cited by 90
Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind, K., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109108 · Cited by 89
“Although increased TREM2 may be protective in AD patients (Ewers et al , 2019), in other neurodegenerative diseases, microglia may be overactivated and become dysfunctional (Heneka et al , 2013; Hong et al , 2016a; Ransohoff, 2016).”
Phagocytic Roles of Glial Cells in Healthy and Diseased Brains
Jung, Y.-J., & Chung, W.-S. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.133 · Cited by 89
Role of microglia-neuron interactions in diabetic encephalopathy
Liu, Y., Li, M., Zhang, Z., Ye, Y., & Zhou, J. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.005 · Cited by 93
Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
Liu, P., Wang, Y., Sun, Y., & Peng, G. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s357558 · Cited by 89
“Microglia eliminate synapses through the complement pathway.(46)”
Gullotta, G. S., Costantino, G., Sortino, M. A., & Spampinato, S. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119144 · Cited by 111
Carling, G. K., Fan, L., Foxe, N. R., Norman, K., Wong, M. Y., Zhu, D., Corona, C., Razzoli, A., Yu, F., Yarahmady, A., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.006 · Cited by 89
Phagocytic astrocytes: Emerging from the shadows of microglia
Konishi, H., Koizumi, S., & Kiyama, H. (2022) · Glia · doi:10.1002/glia.24145 · Cited by 88
Complement C7is a novel risk gene for Alzheimer's disease in Han Chinese
Zhang, D., Fan, Y., Xu, M., Wang, G., Wang, D., Li, J., Kong, L., Zhou, H., Luo, R., Bi, R., et al. (2018) · National Science Review · doi:10.1093/nsr/nwy127 · Cited by 95
“Recent studies reported that the initial componentC1q and the central component C3 contribute to early synapse loss in response to Aβ and/or viral infection in Alzheimer’s disease [60,61].”
InfluentialKim, D. K., Han, D., Park, J., Choi, H., Park, J.-C., Cha, M.-Y., Woo, J., Byun, M. S., Lee, D. Y., Kim, Y., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0326-z · Cited by 85
Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
Frost, G. R., Jonas, L. A., & Li, Y.-M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00337 · Cited by 87
Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis
Dols-Icardo, O., Montal, V., Sirisi, S., López-Pernas, G., Cervera-Carles, L., Querol-Vilaseca, M., Muñoz, L., Belbin, O., Alcolea, D., Molina-Porcel, L., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000829 · Cited by 86
“Recent studies in other neurodegenerative diseases have suggested that microglia are a key and early mediator of synapse loss through phagocytosis induced by the complement cascade.(33,34) Our gene expression data show an increased expression of some key complement cascade-related genes and the most significant enrich…”
BackgroundKrukowski, K., Nolan, A., Becker, M., Picard, K., Vernoux, N., Frias, E. S., Feng, X., Tremblay, M., & Rosi, S. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.210 · Cited by 88
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease
Liu, S., Butler, C. A., Ayton, S., Reynolds, E. C., & Dashper, S. G. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2163613 · Cited by 107
“Gingipains also have the potential to exploit the complement system to facilitate bystander injury of brain structures, such as synapse pruning and neuronal death observed in AD, which is attributed, at least in part, to microglial complement activation (Hong et al. 2016; Dejanovic et al. 2018).”
BackgroundMicroglia communication: parallels between aging and Alzheimer's disease
Udeochu, J. C., Shea, J. M., & Villeda, S. A. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12307 · Cited by 87
“Consistent with reports on the aged brain, similar changes in microglia process dynamics are observed in the context of AD.”
BackgroundInfluentialRoles for neuronal and glial autophagy in synaptic pruning during development
Lieberman, O. J., McGuirt, A. F., Tang, G., & Sulzer, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.017 · Cited by 87
Brody, D. L., Jiang, H., Wildburger, N., & Esparza, T. J. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0293-3 · Cited by 87
“in specific microglial and astroglial phenotypes induced in the vicinity of plaques [37, 38], and these”
BackgroundHsu, H.-W., Bondy, S. C., & Kitazawa, M. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy025 · Cited by 90
“…involvement of microglia and neuroinflammation in AD has recently emerged as a significant factor and unregulated activation of microglia and astrocytes promotes excessive synaptic pruning, impairment of Ab clearance, and neurotoxicity (Hong et al., 2016; Liddelow et al., 2017; Yuan et al., 2016).”
BackgroundMolecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
Marttinen, M., Takalo, M., Natunen, T., Wittrahm, R., Gabbouj, S., Kemppainen, S., Leinonen, V., Tanila, H., Haapasalo, A., & Hiltunen, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00963 · Cited by 88
Polygala tenuifolia : a source for anti-Alzheimer’s disease drugs
Deng, X., Zhao, S., Liu, X., Han, L., Wang, R., Hao, H., Jiao, Y., Han, S., & Bai, C. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1758732 · Cited by 92
“Pathological hallmarks of AD include senile plaque, neurofibrillary tangles (NFTs), synaptic loss and neuronal dysfunction (Hong et al. 2016; Das and Yan 2017; Ishizuka and Hanamura 2017).”
BackgroundMetabolic Dysfunction in Alzheimer’s Disease: From Basic Neurobiology to Clinical Approaches
Clarke, J. R., Ribeiro, F. C., Frozza, R. L., De Felice, F. G., & Lourenco, M. V. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179911 · Cited by 87
“Finally, reactive microglia induce synapse loss in AD models by stripping off synapses through a complement-dependent recognition system [138, 139].”
Oosterhof, N., Holtman, I. R., Kuil, L. E., van der Linde, H. C., Boddeke, E., Eggen, B. J. L., & van Ham, T. J. (2016) · Glia · doi:10.1002/glia.23083 · Cited by 95
“…high microglia-specific expression of components of the complement system, including C1q homologs C1qa and C1qb, components of the complement receptor 3 (CR3) complex, and progranulin, all of which have been shown to be involved in synaptic pruning in mice (Hong et al., 2016; Lui et al., 2016).”
BackgroundDendritic Spines: Mediators of Cognitive Resilience in Aging and Alzheimer’s Disease
Walker, C. K., & Herskowitz, J. H. (2021) · The Neuroscientist · doi:10.1177/1073858420945964 · Cited by 86
Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.585833 · Cited by 100
“et al. (2014). The impact of microglial activation on blood-brain barrier in brain diseases.”
BackgroundHan, X., Xu, T., Ding, C., Wang, D., Yao, G., Chen, H., Fang, Q., Hu, G., & Sun, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00867-y · Cited by 96
“Synapse loss is a hallmark central to many neurodegenerative processes, such as aging, AD, and schizophrenia.(14,42) The unbiased identification of alterations in genes involved in synaptic function, quantified reductions in synaptic terminals within hippocampal CA1/3, and Fig.”
BackgroundBrody, A. H., & Strittmatter, S. M. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.09.007 · Cited by 86
“For example, Aβo may trigger microglial- and/or compliment-mediated attack on the synapse (Hong et al., 2016).”
BackgroundJackson, R. J., Keiser, M. S., Meltzer, J. C., Fykstra, D. P., Dierksmeier, S. E., Hajizadeh, S., Kreuzer, J., Morris, R., Melloni, A., Nakajima, T., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.024 · Cited by 86
Oligodendrocytes in Alzheimer’s disease pathophysiology
Kedia, S., & Simons, M. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01873-x · Cited by 86
“Likewise, components from the complement sys-tem can assist through opsonization-mediated clearing of apoptotic debris and cellular fragments during brain injury, but they can also contribute to neurodegeneration by their role in synapse elimination 48 .”
Hoeijmakers, L., Heinen, Y., van Dam, A.-M., Lucassen, P. J., & Korosi, A. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00398 · Cited by 85
TREM2‐dependent effects on microglia in Alzheimer's disease
Zhou, Y., Ulland, T. K., & Colonna, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00202 · Cited by 82
Chu, X., Cao, L., Yu, Z., Xin, D., Li, T., Ma, W., Zhou, X., Chen, W., Liu, D., & Wang, Z. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1488-2 · Cited by 85
“For example, C1q and the classical complement cascade are strongly activated in Alzheimer's disease and are associated with synapse loss [34].”
Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy
Alawieh, A. M., Langley, E. F., Feng, W., Spiotta, A. M., & Tomlinson, S. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2462-19.2020 · Cited by 84
“Prior work using models of neurodegenerative disorders demonstrated that loss of synapses is an early predictor of cognitive decline (Terry et al., 1991; Stephan et al., 2012; Hong et al., 2016; Vasek et al., 2016).”
BackgroundMethodApolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework
Mentis, A.-F. A., Dardiotis, E., & Chrousos, G. P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0731-7 · Cited by 85
“Another possibility could be that the altered neuroinflammatory response [21, 24, 193] and proinflammatory mediator levels (such as chitinase-3-like protein 1, and several cytokines, such as TNF-alpha, interleukin-1 receptor antagonist, and complement component C1q and 3) in the CSF of patients with AD [195–196] may b…”
BackgroundKorai, S. A., Ranieri, F., Lazzaro, V. D., Papa, M., & Cirillo, G. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.587771 · Cited by 109
Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer’s disease
Cai, H., Pang, Y., Wang, Q., Qin, W., Wei, C., Li, Y., Li, T., Li, F., Wang, Q., Li, Y., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01133-1 · Cited by 90
“Furthermore, mouse models showed that dysregulated C1q-mediated synaptic pruning and/ or spine density loss was associated with behavioral deficits, implicating its detrimental role in the inflammatory process [27].”
BackgroundZheng, Q., Li, G., Wang, S., Zhou, Y., Liu, K., Gao, Y., Zhou, Y., Zheng, L., Zhu, L., Deng, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe1340 · Cited by 85
Welch, G. M., Boix, C. A., Schmauch, E., Davila-Velderrain, J., Victor, M. B., Dileep, V., Bozzelli, P. L., Su, Q., Cheng, J. D., Lee, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4662 · Cited by 84
“10 of 18 a corresponding decrease in the complement protein C1q, which is implicated in synaptic loss in other models of neurodegeneration (40, 41).”
BackgroundSchartz, N. D., Wyatt‐Johnson, S. K., Price, L. R., Colin, S. A., & Brewster, A. L. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.10.012 · Cited by 96
“Known for decades as first responders during pathogenic attack in the periphery, its role in the central nervous system has recently been under investigation (Hong et al., 2016; Schafer et al., 2013; Stephan et al., 2012; Vasek et al., 2016).”
BackgroundCa2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases
Sompol, P., & Norris, C. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00199 · Cited by 82
Haure-Mirande, J.-V., Wang, M., Audrain, M., Fanutza, T., Kim, S. H., Heja, S., Readhead, B., Dudley, J. T., Blitzer, R. D., Schadt, E. E., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0255-6 · Cited by 84
Emerging Roles of Complement in Psychiatric Disorders
Druart, M., & Le Magueresse, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00573 · Cited by 84
“Synapse loss and microglial engulfment are prevented in CR3 KO mice (109).”
BackgroundThe Mononuclear Phagocytic System. Generation of Diversity
Gordon, S., & Plüddemann, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01893 · Cited by 109
“With the aid of these reagents we identified substantial morphologic and antigenic heterogeneity of resident murine macrophages in different tissue environments such as CNS, spleen and bone marrow (28).”
BackgroundInfluentialSong, S., Yu, L., Hasan, M. N., Paruchuri, S. S., Mullett, S. J., Sullivan, M. L. G., Fiesler, V. M., Young, C. B., Stolz, D. B., Wendell, S. G., et al. (2022) · Communications Biology · doi:10.1038/s42003-021-02984-4 · Cited by 83
Scott-Hewitt, N., Mahoney, M., Huang, Y., Korte, N., Yvanka de Soysa, T., Wilton, D. K., Knorr, E., Mastro, K., Chang, A., Zhang, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.058 · Cited by 85
Self-citationInitiative, F. T. A. D. N., Takahashi, H., Klein, Z. A., Bhagat, S. M., Kaufman, A. C., Kostylev, M. A., Ikezu, T., & Strittmatter, S. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1668-z · Cited by 83
Simon, E., Obst, J., & Gomez-Nicola, D. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.059 · Cited by 83
Dobó, J., Kocsis, A., & Gál, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01851 · Cited by 91
“If these processes, essential during normal brain development, are pathologically upregulated during adulthood, they can contribute to the development of neurodegenerative diseases, such as Alzheimer disease and frontal temporal dementia (61).”
BackgroundWang, H., Li, Y., Ryder, J. W., Hole, J. T., Ebert, P. J., Airey, D. C., Qian, H.-R., Logsdon, B., Fisher, A., Ahmed, Z., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0296-y · Cited by 83
Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends
Zeng, H., Qi, Y., Zhang, Z., Liu, C., Peng, W., & Zhang, Y. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.014 · Cited by 83
A Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease
Luchena, C., Zuazo-Ibarra, J., Valero, J., Matute, C., Alberdi, E., & Capetillo-Zarate, E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.844534 · Cited by 82
Chen, Z., Zhao, X., Wang, S., Cai, R., Liu, Q., Ye, H., Wang, M.-J., Peng, S., Xue, W., Zhang, Y.-X., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01979-2 · Cited by 98
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.